STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[424B3] SciSparc Ltd. Prospectus Filed Pursuant to Rule 424(b)(3)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
424B3
Rhea-AI Filing Summary

SciSparc Ltd. filed a prospectus supplement to update its F-4 prospectus with a Form 6-K detailing a new Framework Agreement with AutoMax Motors. The parties mutually terminated their prior merger agreement, rendering it null and void effective October 6, 2025.

The agreement sets specific loan repayments to SciSparc: AutoMax will repay a $4.25 million loan with 9% annual compound interest in a single lump-sum on January 1, 2028. A separate $2.0 million loan will be repaid in $60,000 monthly installments starting November 20, 2025, with 8% annual compound interest accruing to each payment date, plus $114,523 of accrued interest through November 20, 2025. The supplement incorporates the 6-K and attaches the Framework Agreement and related press release as exhibits.

Positive
  • None.
Negative
  • None.

Insights

Merger terminated; cash recoveries scheduled via two AutoMax loans.

SciSparc and AutoMax mutually ended their merger. The Framework Agreement pivots the relationship to debt recovery: a $4.25M loan at 9% compounding due in a single payment on January 1, 2028, and a separate $2.0M loan amortizing via $60,000 monthly installments starting November 20, 2025 at 8% compounding.

Cash inflows depend on AutoMax making scheduled payments. The agreement lists accrued interest of $114,523 through November 20, 2025 on the $2.0M loan, clarifying near-term amounts. No equity issuance terms are discussed in this update.

Key dates are the installment start on November 20, 2025 and the lump-sum due January 1, 2028. Subsequent filings may provide status updates on collections and any changes to terms.

Filed pursuant to Rule 424(b)(3)
Registration No. 333-282351

PROSPECTUS SUPPLEMENT NO. 1

(to Prospectus dated July 21, 2025)

 

SCISPARC LTD.

 

This prospectus supplement updates, amends and supplements the prospectus contained in our Registration Statement on Form F-4(Registration No. 333-282351), effective as of July 21, 2025 (as supplemented or amended from time to time, the “Prospectus”). Capitalized terms used in this prospectus supplement and not otherwise defined herein have the meanings specified in the Prospectus.

 

This prospectus supplement is being filed to update, amend and supplement the information included in the Prospectus with the information contained in our Report of Foreign Private Issuer on Form 6-K filed with the Securities and Exchange Commission on October 6, 2025, which is set forth below.

 

This prospectus supplement is not complete without the Prospectus. This prospectus supplement should be read in conjunction with the Prospectus, which is to be delivered with this prospectus supplement, and is qualified by reference thereto, except to the extent that the information in this prospectus supplement updates or supersedes the information contained in the Prospectus. Please keep this prospectus supplement with your Prospectus for future reference.

 

The date of this prospectus supplement is November 4, 2025.

 

 

 

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 6-K

 

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16

under the Securities Exchange Act of 1934

 

For the month of October 2025

 

Commission File Number: 001-38041

 

SCISPARC LTD.

(Translation of registrant’s name into English)

 

20 Raul Wallenberg Street, Tower A,

Tel Aviv 6971916 Israel

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F   Form 40-F 

 

 

 

 

 

 

CONTENTS

 

On October 6, 2025, SciSparc Ltd. (the “Company”) announced the entry into a framework agreement by and among the Company, AutoMax Motors Ltd. (“AutoMax”) and SciSparc Merger Sub Ltd. (“Merger Sub”), dated as of October 6, 2025 (the “Framework Agreement”). The Framework Agreement sets forth the following: (i) the termination of that certain Agreement and Plan of Merger by and between the Company, AutoMax and Merger Sub, dated as of April 10, 2024, as amended (the “Merger Agreement”), pursuant to a mutual agreement between the parties in accordance with section 9.1(a) of the Merger Agreement, according to which, effective as of the date hereof, the Merger Agreement shall be null and void and of no further force or effect; (ii) the repayment by AutoMax of a $4.25 million loan amount and interest of 9% per annum, compounded annually, under a loan agreement dated January 14, 2024, as amended, in a one lump-sum payment on January 1, 2028; and (iii) the repayment by AutoMax of a $2.0 million loan amount, under a loan agreement dated February 24, 2025 in monthly installments starting on November 20, 2025, of $60,000 each and the interest of 8% per annum, compounded annually up to each actual payment date, in addition to the payment of all interest accrued on such loan from its effective date until November 20, 2025, in the sum of $114,523.

 

The foregoing description of the Framework Agreement does not purport to be complete and is qualified in its entirety by the terms of the Framework Agreement, which is attached hereto as Exhibit 99.1, and is incorporated herein by reference.

 

The Company’s press release dated October 6, 2025, announcing the signing of the Framework Agreement, is attached hereto as Exhibit 99.2.

 

This Report of Foreign Private Issuer on Form 6-K is incorporated by reference into the Company’s registration statements on Form F-3 (File Nos. 333-286099333-275305333-269839333-266047333-248670 and 333-255408) and on Form S-8 (File Nos. 333-278437333-225773 and 333-286791) filed with the Securities and Exchange Commission to be a part thereof from the date on which this report is submitted, to the extent not superseded by documents or reports subsequently filed or furnished.

 

EXHIBIT INDEX

 

Exhibit   Description of Exhibit
99.1   Framework Agreement, dated as of October 6, 2025, by and among SciSparc Ltd., SciSparc Merger Sub Ltd., and AutoMax Ltd.
99.2   Press release issued by SciSparc Ltd. titled “SciSparc Ltd. Announces Framework Agreement Regarding Merger with AutoMax Motors.”  

 

1

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  SciSparc Ltd.
     
Date: October 6, 2025 By: /s/ Oz Adler
  Name:  Oz Adler
  Title: Chief Executive Officer and Chief Financial Officer

 

 

2

 

 

FAQ

What did SPRC announce regarding the AutoMax transaction?

SciSparc and AutoMax mutually terminated their merger agreement effective October 6, 2025, under a new Framework Agreement.

What are the repayment terms for AutoMax’s $4.25 million loan to SPRC?

AutoMax will repay $4.25 million plus 9% annual compound interest in one lump-sum on January 1, 2028.

How will the $2.0 million AutoMax loan to SPRC be repaid?

In $60,000 monthly installments starting November 20, 2025, with 8% annual compound interest to each payment date.

How much accrued interest is due on the $2.0 million loan as of November 20, 2025?

The Framework Agreement specifies $114,523 of accrued interest through November 20, 2025.

Which filings does this update incorporate for SPRC?

The Form 6-K is incorporated by reference into SciSparc’s Forms F-3 and S-8 listed in the document.

What exhibits are attached to the SPRC update?

Exhibit 99.1 is the Framework Agreement; Exhibit 99.2 is the press release announcing it.
Scisparc

NASDAQ:SPRC

SPRC Rankings

SPRC Latest News

SPRC Latest SEC Filings

SPRC Stock Data

4.33M
1.62M
0%
0.5%
9.3%
Biotechnology
Healthcare
Link
Israel
Tel Aviv